Transient Ischemic Attack

Improved Stroke Survival Outcomes With Antihypertensive Prescription at Discharge

Improved Stroke Survival Outcomes With Antihypertensive Prescription at Discharge

By

It is possible that many patients who were not prescribed antihypertensive medications at discharge had contraindications to these agents, limiting the findings.

Predicting Major Bleeding in Patients With Stroke on Antiplatelet Agents

Predicting Major Bleeding in Patients With Stroke on Antiplatelet Agents

By

There are a limited number of prediction models that identify patients at risk of major bleeding after stroke or TIA.

Even Stable Survivors Face 5-Year Risk of Second Stroke

Even Stable Survivors Face 5-Year Risk of Second Stroke

The risk of a second stroke or transient ischemic attack (TIA) remains considerable for at least 5 years after the first event.

Sign Up for Free e-newsletters

CME Focus